Company news
Verrica Pharmaceuticals Inc. news in 2019
Verrica Pharmaceuticals Inc.'s news releases, calls and decks from 2019, newest first.
Verrica Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
November 26, 2019
Verrica Pharmaceuticals Announces Passing of Board of Directors Member Glenn Oclassen
November 18, 2019
Verrica Pharmaceuticals Reports Third Quarter 2019 Financial Results
November 5, 2019
Verrica Pharmaceuticals Announces Presentation of Positive Data from Clinical Trials of VP-102 at the 2019 39th Annual Fall Clinical Dermatology Conference
October 17, 2019
Verrica Pharmaceuticals Appoints Eugene Scavola to the Position of Executive Vice President, Technical Operations
October 8, 2019
Verrica Pharmaceuticals Announces Leadership Team Update
October 6, 2019
Verrica Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration for VP-102 for the Treatment of Molluscum Contagiosum
September 15, 2019
Decks in 2019
- Investor Presentation (October 2019)
Investor deck · 51 slides · Oct 18, 2019
- Technical Presentation (June 2019)
Technical · 13 slides · Jun 27, 2019
- Technical Presentation (January 2019)
Technical · 15 slides · Jan 3, 2019